Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4910)
All Articles published online
|
Publishing Process of This Article
|
Jul 27, 2013 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zachou K, Sarantopoulos A, Gatselis NK, Vassiliadis T, Gabeta S, Stefos A, Saitis A, Boura P, Dalekos GN. Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat. World J Hepatol 2013; 5(7): 387-392 [PMID: 23898372 DOI: 10.4254/wjh.v5.i7.387] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v5/i7/387.htm |
| Number | Citing Articles |
| 1 |
Edward R. Scheffer Cliff, Joe Sasadeusz, Kumar Visvanathan, Andrew Grigg. Very late-onset hepatitis B reactivation following chemoimmunotherapy. Leukemia & Lymphoma 2022; 63(4): 991 doi: 10.1080/10428194.2021.2010066
|
| 2 |
Ivan Noreña, Mario Fernández-Ruiz, José María Aguado. Viral infections in the biologic therapy era. Expert Review of Anti-infective Therapy 2018; 16(10): 781 doi: 10.1080/14787210.2018.1521270
|
| 3 |
Tsuyoshi Odai, Takeo Isozaki, Tsuyoshi Kasama, Hiroaki Ogata, Eriko Kinugasa. Therapeutic Efficacy of Leukocytapheresis in a Pregnant Woman with Refractory Adult-onset Still's Disease. Internal Medicine 2015; 54(17): 2261 doi: 10.2169/internalmedicine.54.4271
|
| 4 |
Koji Yokoyama, Hideki Kumagai, Masaharu Takahashi, Shigeo Nagashima, Hiroaki Okamoto, Takanori Yamagata. Occult hepatitis B virus infection in immunized children born to carrier mothers. Pediatrics International 2017; 59(9): 1010 doi: 10.1111/ped.13352
|
| 5 |
Eirini I Rigopoulou, Kalliopi Zachou, Nikolaos K Gatselis, Georgia Papadamou, George K Koukoulis, George N Dalekos. Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome. World Journal of Hepatology 2013; 5(10): 577-583 doi: 10.4254/wjh.v5.i10.577
|
| 6 |
Anais Vallet-Pichard, Stanislas Pol. Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal. Therapeutic Advances in Gastroenterology 2014; 7(4): 148 doi: 10.1177/1756283X14524614
|
| 7 |
Rosana Quintana, M. Emilia Sattler, Marisol Ferrer. Mediastinal polyadenopathies and differential diagnoses in systemic lupus erythematosus. Case report and literature review. Revista Argentina de Reumatología 2019; : 28 doi: 10.47196/rar.v30i3.444
|
| 8 |
Nuria Dominguez, Maria Luisa Manzano, Raquel Muñoz, Ana Martin, Inmaculada Fernandez, Gregorio Castellano. Late reactivation of occult hepatitis B virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen. Leukemia & Lymphoma 2015; 56(4): 1160 doi: 10.3109/10428194.2014.947978
|
| 9 |
Hiroshi Kamitsukasa, Masanobu Iri, Akihisa Tanaka, Shigeo Nagashima, Masaharu Takahashi, Tsutomu Nishizawa, Hiroaki Okamoto. Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection. Journal of Medical Virology 2015; 87(4): 589 doi: 10.1002/jmv.24115
|
| 10 |
K. Zachou, P. Muratori, G. K. Koukoulis, A. Granito, N. Gatselis, A. Fabbri, G. N. Dalekos, L. Muratori. Review article: autoimmune hepatitis - current management and challenges. Alimentary Pharmacology & Therapeutics 2013; 38(8): 887 doi: 10.1111/apt.12470
|
| 11 |
Ji Won Han, Hyun Yang, Hae Lim Lee, Si Hyun Bae, Jong Young Choi, Jong‐Wook Lee, Hee Je Kim, Seok Lee, Seok Goo Cho, Chang Ki Min, Dong Wook Kim, Seung Kew Yoon. Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies. Hepatology Research 2016; 46(7): 657 doi: 10.1111/hepr.12603
|
| 12 |
Daisuke Okamoto, Haruo Nakayama, Tomoyuki Ikeda, Shinichi Ikeya, Shigeo Nagashima, Masaharu Takahashi, Yoshiki Sugai, Hiroaki Okamoto. Molecular analysis of the interspousal transmission of hepatitis B virus in two Japanese patients who acquired fulminant hepatitis B after 50 and 49 years of marriage. Journal of Medical Virology 2014; 86(11): 1851 doi: 10.1002/jmv.24040
|
| 13 |
Tamer A. Elbedewy, Hossam Eldin A. Elashtokhy, Enaam S. Rabee, Gamal E. Kheder. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: Significance of hepatitis B core antibodies screening. Journal of the Egyptian National Cancer Institute 2015; 27(1): 11 doi: 10.1016/j.jnci.2015.01.004
|
| 14 |
Shunsuke Mori, Shigetoshi Fujiyama. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations. World Journal of Gastroenterology 2015; 21(36): 10274-10289 doi: 10.3748/wjg.v21.i36.10274
|
| 15 |
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host. 2016; : 69 doi: 10.1128/9781555819040.ch3
|
| 16 |
Sang Hee Song, Seong Gyu Hwang. Occult Hepatitis B Virus Infection: Transmission and Reactivation. The Korean Journal of Gastroenterology 2013; 62(3): 148 doi: 10.4166/kjg.2013.62.3.148
|
| 17 |
Nikolaos Papadopoulos, Melanie Deutsch, Spilios Manolakopoulos, Chrysoula Bitsi, Helias Michalakeas, Helias Poulakidas, Eftychia Tsironi, Stavroula Giannouli, George V. Papatheodoridis, John Koskinas, Dimitrios Pectasides. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience. European Journal of Gastroenterology & Hepatology 2017; 29(1): 56 doi: 10.1097/MEG.0000000000000749
|
| 18 |
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and D. Microbiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
|
| 19 |
H. Dele Davies, Carrie L. Byington, Yvonne A. Maldonado, Elizabeth D. Barnett, Kathryn M. Edwards, Ruth Lynfield, Flor M. Munoz-Rivas, Dawn L. Nolt, Ann-Christine Nyquist, Mobeen H. Rathore, Mark H. Sawyer, William J. Steinbach, Tina Q. Tan, Theoklis E. Zaoutis. Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children. Pediatrics 2016; 138(2) doi: 10.1542/peds.2016-1209
|
| 20 |
A. El Mekkaoui, Z. Benbrahim, O. El Mesbahi, A. Ibrahimi, N. Aqodad. Traitement préemptif de la réactivation de l’hépatite virale B des patients sous chimiothérapie anticancéreuse. Journal Africain du Cancer / African Journal of Cancer 2014; 6(1): 47 doi: 10.1007/s12558-013-0299-4
|
| 21 |
Raika Jamali. The Importance of Occult Hepatitis B Infection Screening in Pre-Transplant Evaluation. Thrita 2014; 3(2) doi: 10.5812/thrita.16044
|
| 22 |
C. Sagnelli, M. Macera, M. Pisaturo, R. Zampino, M. Coppola, E. Sagnelli. Occult HBV infection in the oncohematological setting. Infection 2016; 44(5): 575 doi: 10.1007/s15010-016-0891-1
|
| 23 |
Yu-Hung Wang, Ja-Der Liang, Wang-Huei Sheng, Feng-Ming Tien, Chien-Yuan Chen, Hwei-Fang Tien. Hepatitis B reactivation during treatment of tyrosine kinase inhibitors—Experience in 142 adult patients with chronic myeloid leukemia. Leukemia Research 2019; 81: 95 doi: 10.1016/j.leukres.2019.05.001
|
| 24 |
Alissa Visram, Jordan J. Feld. Defining and grading HBV reactivation. Clinical Liver Disease 2015; 5(2): 35 doi: 10.1002/cld.426
|
| 25 |
H. Dele Davies. Principles and Practice of Pediatric Infectious Diseases. 2018; : 651 doi: 10.1016/B978-0-323-40181-4.00107-9
|
| 26 |
Satoshi Takakusagi, Hitoshi Takagi, Yozo Yokoyama, Kazuko Kizawa, Kyoko Marubashi, Takashi Kosone, Shigeo Nagashima, Masaharu Takahashi, Kazumoto Murata, Hiroaki Okamoto. Spontaneous reactivation of hepatitis B virus with a frameshift mutation in the precore region in an elderly hepatitis B virus carrier with lifestyle-related diseases. Clinical Journal of Gastroenterology 2021; 14(4): 1202 doi: 10.1007/s12328-021-01423-5
|
| 27 |
Junichi Muraishi, Michihiko Shibata, Yuichi Honma, Masaaki Hiura, Shintaro Abe, Masaru Harada. Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma. Internal Medicine 2017; 56(15): 1967 doi: 10.2169/internalmedicine.56.8233
|
| 28 |
H. Dele Davies. Principles and Practice of Pediatric Infectious Diseases. 2023; : 674 doi: 10.1016/B978-0-323-75608-2.00107-5
|